Professor Yaakov Bickels is a well-known orthopedic oncologist, the most sought-after among similar specialists in Israel. His meaningful contribution to the development of surgery was appreciated by experts in medical circles around the world. His efforts have given back hundreds of lives of patients with aggressive diagnoses previously considered irreversible and incurable.
The professor received his basic education at the Faculty of Medicine at the University of Israel, after which he interned at the world’s leading medical institutions. He quickly began to combine his academic and practical activities. After achieving certain results, he accepted a teaching position at Tel Aviv Medical University and also became an advisor to a medical insurance organization on issues related to onco-orthopedics. For his excellent work and dedication, he was soon appointed head of the department for the treatment of metastatic bone disease M.C. “Ichilov-Suraski.
Professor Bickels specializes in the most complex endoprosthetic operations for malignant tumors. In planning surgery, the professor is guided by the goal of maximum removal of the malignant lesion, preserving the limb, with the removed area replaced by an artificial implant. He also brilliantly performs surgeries to replace large bone fragments and affected joints. It is noted that after such operations, patients quickly return to their normal lifestyle and can even go in for sports.
Jacob Bickels is a specialist who has over 20 years of clinical practice in his arsenal. He regularly shares his invaluable experience and skills with his colleagues through presentations at various symposia and conferences. He is a key figure in international associations, as evidenced by numerous testimonials from colleagues and superior experts. The results of his research are often published in prestigious international medical journals.
Patients can go to him for medical care that includes innovative treatments and diagnostics. Thanks to it such diseases as chondroblastoma, chondrosarcoma, Ewing’s sarcoma, myeloma disease and other diseases characterized by bone tissue damage are no longer a problem.
